These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 19041023

  • 1. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P, Fraggetta F, Galia A, Grasso G, Piccolo S, Aragona F.
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P, Aragona F.
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [Abstract] [Full Text] [Related]

  • 4. Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
    Isbarn H, Karakiewicz PI, Vogel S, Jeldres C, Lughezzani G, Briganti A, Montorsi F, Perrotte P, Ahyai SA, Budäus L, Eichelberg C, Heuer R, Köllermann J, Sauter G, Schlomm T, Steuber T, Haese A, Zacharias M, Fisch M, Heinzer H, Huland H, Chun FK, Graefen M.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):784-7. PubMed ID: 19864083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Aug 01; 108(3):366-71. PubMed ID: 21087451
    [Abstract] [Full Text] [Related]

  • 9. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
    Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ.
    J Urol; 2005 Dec 01; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
    [Abstract] [Full Text] [Related]

  • 10. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt.
    Müntener M, Kunz U, Eichler K, Puhan M, Schmid DM, Sulser T, Strebel RT.
    Urol Int; 2010 Dec 01; 84(2):141-6. PubMed ID: 20215816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is PCA3 score useful in preoperative staging of a single microfocus of prostate cancer diagnosed at saturation biopsy?
    Pepe P, Fraggetta F, Galia A, Aragona F.
    Urol Int; 2012 Dec 01; 89(2):143-7. PubMed ID: 22868485
    [Abstract] [Full Text] [Related]

  • 13. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
    Falzarano SM, Zhou M, Hernandez AV, Moussa AS, Jones JS, Magi-Galluzzi C.
    Urology; 2010 Sep 01; 76(3):682-7. PubMed ID: 20206973
    [Abstract] [Full Text] [Related]

  • 14. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C, Louis P, Civantos F, Soloway MS.
    J Urol; 1999 Feb 01; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [Abstract] [Full Text] [Related]

  • 15. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May 01; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 16. Does Ki-67 staining improve quantitative histology in preoperative prostate cancer staging?
    Pepe P, Fraggetta F, Candiano G, Aragona F.
    Arch Ital Urol Androl; 2012 Mar 01; 84(1):32-5. PubMed ID: 22649958
    [Abstract] [Full Text] [Related]

  • 17. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 18. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
    Haese A, Chaudhari M, Miller MC, Epstein JI, Huland H, Palisaar J, Graefen M, Hammerer P, Poole EC, O'Dowd GJ, Partin AW, Veltri RW.
    Cancer; 2003 Feb 15; 97(4):969-78. PubMed ID: 12569595
    [Abstract] [Full Text] [Related]

  • 19. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA, Lee HJ, Kim KG, Kim SH, Lee SE, Choe GY.
    Int J Urol; 2007 Aug 15; 14(8):704-8. PubMed ID: 17681059
    [Abstract] [Full Text] [Related]

  • 20. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA.
    Urology; 2004 Sep 15; 64(3):544-50. PubMed ID: 15351590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.